Order Article Reprints

Hayasaki A, Isaji S, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, et al. Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer. Cancers. 2018; 10(3):65. https://doi.org/10.3390/cancers10030065

Hayasaki, Aoi, Shuji Isaji, Masashi Kishiwada, Takehiro Fujii, Yusuke Iizawa, Hiroyuki Kato, Akihiro Tanemura, Yasuhiro Murata, Yoshinori Azumi, Naohisa Kuriyama, and et al. 2018. "Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer" Cancers 10, no. 3: 65. https://doi.org/10.3390/cancers10030065

Hayasaki, A., Isaji, S., Kishiwada, M., Fujii, T., Iizawa, Y., Kato, H., Tanemura, A., Murata, Y., Azumi, Y., Kuriyama, N., Mizuno, S., Usui, M., & Sakurai, H. (2018). Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer. Cancers, 10(3), 65. https://doi.org/10.3390/cancers10030065